A vast and growing majority of American companies doing business in China have been negatively affected by the US-China trade war, an expert on the matter said at a recent meeting.
FDA warned pregnant and breast-feeding women yesterday to avoid CBD, THC and marijuana in any form, including the proliferation of food, supplements and cosmetics containing CBD and other cannabis-derived ingredients that currently are flooding the market...
NFL player Brandon Copeland, who had been suspended over a failed drug test, said he plans to file a lawsuit against a company that he claims gave him "contaminated" supplements.
New Trump Administration executive orders on guidance documents from regulatory agencies likely will affect the dietary supplement industry, an attorney says.
Early data on the Food Safety Modernization Act suggests the new law is working as compliance is improving and recalls have hit a five year low. A newly launched web portal will help track that data.
The International Probiotics Association will host its fourth IPA DC Workshop with insights from a range of experts and stakeholders, including the FDA/ CFSAN, FTC, and Health Canada. The event is held in conjunction with the US Pharmacopeia.
Yesterday four trade associations representing the dietary supplement industry sent a letter to all 535 members of the US Congress urging them to make CBD a legal dietary ingredient and to give FDA the resources to regulate the sector.
As widely predicted, the plaintiff’s bar has turned its attention to the burgeoning CBD category with a series of lawsuits alleging that products contain “significantly lower levels of CBD than advertised.”
FDA is continuing to crack down on the legality of CBD when a case comes across its desk, despite a call for an official enforcement discretion policy.
President Trump is poised to nominate Oncologist Dr. Stephen Hahn to head the Food and Drug Administration, pending completion of the vetting process, several news outlets are reporting.
AdvoCare, a multi-level marketing company, has agreed to a $150 million fine and a compensation plan restructuring to settle an FTC pyramid scheme case. In addition, the former CEO has agreed to a ban from the industry.
A cannabidiol (CBD) manufacturer is calling for greater regulatory controls after independent analyses of 31 CBD-based products found varying levels of active ingredients as well as CBD-related labelling issues.
CVS has agreed to pay refunds on a brand of memory supplements, according to the Center for Science in the Public Interest, which had sued the company on behalf of consumers.
Herbalife Nutrition has agreed to pay a $20 million fine levied by the US Securities and Exchange Commission to settle a claim that the company has misled investors on its business in China.
